BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32839159)

  • 21. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
    Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
    Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E
    Virchows Arch; 2023 Dec; 483(6):733-749. PubMed ID: 37530791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma.
    Leithäuser F; Bäuerle M; Huynh MQ; Möller P
    Blood; 2001 Nov; 98(9):2762-70. PubMed ID: 11675349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain.
    Shi M; Roemer MG; Chapuy B; Liao X; Sun H; Pinkus GS; Shipp MA; Freeman GJ; Rodig SJ
    Am J Surg Pathol; 2014 Dec; 38(12):1715-23. PubMed ID: 25025450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
    Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
    J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma.
    Li KD; Miles R; Tripp SR; Glenn MJ; Perkins SL; Salama M
    Am J Clin Pathol; 2015 Apr; 143(4):598-604. PubMed ID: 25780014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
    Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
    Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL.
    Chu Y; Awasthi A; Lee S; Edani D; Yin C; Hochberg J; Shah T; Chung TH; Ayello J; van de Ven C; Klein C; Lee D; Cairo MS
    Oncotarget; 2020 Aug; 11(32):3035-3047. PubMed ID: 32850008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant hematopoietic cell lines: in vitro models for the study of primary mediastinal B-cell lymphomas.
    Drexler HG; Ehrentraut S; Nagel S; Eberth S; MacLeod RA
    Leuk Res; 2015 Jan; 39(1):18-29. PubMed ID: 25480038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.
    Jardin F; Pujals A; Pelletier L; Bohers E; Camus V; Mareschal S; Dubois S; Sola B; Ochmann M; Lemonnier F; Viailly PJ; Bertrand P; Maingonnat C; Traverse-Glehen A; Gaulard P; Damotte D; Delarue R; Haioun C; Argueta C; Landesman Y; Salles G; Jais JP; Figeac M; Copie-Bergman C; Molina TJ; Picquenot JM; Cornic M; Fest T; Milpied N; Lemasle E; Stamatoullas A; Moeller P; Dyer MJ; Sundstrom C; Bastard C; Tilly H; Leroy K
    Am J Hematol; 2016 Sep; 91(9):923-30. PubMed ID: 27312795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
    Mottok A; Hung SS; Chavez EA; Woolcock B; Telenius A; Chong LC; Meissner B; Nakamura H; Rushton C; Viganò E; Sarkozy C; Gascoyne RD; Connors JM; Ben-Neriah S; Mungall A; Marra MA; Siebert R; Scott DW; Savage KJ; Steidl C
    Blood; 2019 Sep; 134(10):802-813. PubMed ID: 31292115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary mediastinal B-cell lymphoma: a review of pathology and management.
    van Besien K; Kelta M; Bahaguna P
    J Clin Oncol; 2001 Mar; 19(6):1855-64. PubMed ID: 11251018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.
    Tuveri S; Debackere K; Marcelis L; Dierckxsens N; Demeulemeester J; Dimitriadou E; Dierickx D; Lefesvre P; Deraedt K; Graux C; Michaux L; Cools J; Tousseyn T; Vermeesch JR; Wlodarska I
    Genes Chromosomes Cancer; 2022 Oct; 61(10):603-615. PubMed ID: 35611992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein.
    Weniger MA; Gesk S; Ehrlich S; Martin-Subero JI; Dyer MJ; Siebert R; Möller P; Barth TF
    Genes Chromosomes Cancer; 2007 Apr; 46(4):406-15. PubMed ID: 17243160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-needle aspiration of a primary mediastinal large B-cell lymphoma: a case report with cytologic, histologic, and flow cytometric considerations.
    Hoda RS; Picklesimer L; Green KM; Self S
    Diagn Cytopathol; 2005 Jun; 32(6):370-3. PubMed ID: 15880713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Factors in Familial Manifestation of Primary Mediastinal Large B-Cell Lymphoma over Two Generations.
    Juskevicius D; Lundberg P; Tzankov A; Dirnhofer S; Stenner F
    Pathobiology; 2023; 90(6):422-428. PubMed ID: 37490879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study.
    Zinzani PL; Santoro A; Gritti G; Brice P; Barr PM; Kuruvilla J; Cunningham D; Kline J; Johnson NA; Mehta-Shah N; Manley T; Francis S; Sharma M; Moskowitz AJ
    J Clin Oncol; 2019 Nov; 37(33):3081-3089. PubMed ID: 31398081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary mediastinal large B-cell lymphoma in women: about five cases].
    Ouassou S; Herrak L; Achachi L; Nachite F; Znati K; Ftouh ME
    Pan Afr Med J; 2016; 24():181. PubMed ID: 27795778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas.
    Donzel M; Pesce F; Trecourt A; Groussel R; Bachy E; Ghesquières H; Fontaine J; Benzerdjeb N; Mauduit C; Traverse-Glehen A
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma.
    Copie-Bergman C; Boulland ML; Dehoulle C; Möller P; Farcet JP; Dyer MJ; Haioun C; Roméo PH; Gaulard P; Leroy K
    Blood; 2003 Apr; 101(7):2756-61. PubMed ID: 12446450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.